FAM171B stabilizes vimentin and enhances CCL2-mediated TAM infiltration to promote bladder cancer progression

FRMD3 inhibits the growth and metastasis of breast cancer through the ubiquitination-mediated degradation of vimentin and subsequent impairment of focal adhesion

(2023) Wenjun Shao et al.   Cell Death & Disease

CLDN6 inhibits breast cancer metastasis through WIP-dependent actin cytoskeleton-mediated autophagy

(2023) Yuan Dong et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Targeting HNRNPU to overcome cisplatin resistance in bladder cancer

(2022) Zhen-duo Shi et al.   Molecular Cancer

Spatiotemporal co-dependency between macrophages and exhausted CD8+ T cells in cancer

(2022) Kelly Kersten et al.   CANCER CELL

Roles of vimentin in health and disease

(2022) Karen M. Ridge et al.   GENES & DEVELOPMENT

Clinical relevance of tumour-associated macrophages

(2022) Mikael J. Pittet et al.   Nature Reviews Clinical Oncology

Current best practice for bladder cancer: a narrative review of diagnostics and treatments

(2022) Eva Compérat et al.   LANCET

FAM171B as a Novel Biomarker Mediates Tissue Immune Microenvironment in Pulmonary Arterial Hypertension

(2022) Lai-Hao Qu et al.   MEDIATORS OF INFLAMMATION

Interferon-dependent SLC14A1+ cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer

(2022) Zikun Ma et al.   CANCER CELL

Vimentin epigenetic deregulation in Bladder Cancer associates with acquisition of invasive and metastatic phenotype through epithelial-to-mesenchymal transition

(2022) Sara Monteiro-Reis et al.   International Journal of Biological Sciences

eggNOG 6.0: enabling comparative genomics across 12 535 organisms

(2022) Ana Hernández-Plaza et al.   NUCLEIC ACIDS RESEARCH

PD-L1 upregulation promotes drug-induced pulmonary fibrosis by inhibiting vimentin degradation

(2022) Qing Li et al.   PHARMACOLOGICAL RESEARCH

HNRNPU promotes the progression of triple-negative breast cancer via RNA transcription and alternative splicing mechanisms

(2022) Bo-yue Han et al.   Cell Death & Disease

Neoadjuvant immunotherapy, chemotherapy, and combination therapy in muscle-invasive bladder cancer: A multi-center real-world retrospective study

(2022) Jiao Hu et al.   Cell Reports Medicine

Recent advances in neoadjuvant immunotherapy for urothelial bladder cancer: What to expect in the near future

(2021) M. Rey-Cárdenas et al.   CANCER TREATMENT REVIEWS

CMTM6 promotes migration, invasion, and EMT by interacting with and stabilizing vimentin in hepatocellular carcinoma cells

(2021) Xiaoting Huang et al.   Journal of Translational Medicine

FAM171B is a novel polyglutamine protein widely expressed in the mammalian brain

(2021) Quan Tran et al.   BRAIN RESEARCH

Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting

(2021) Maosen Xu et al.   CELL PROLIFERATION

Tumor-Associated Macrophages in Bladder Cancer: Biological Role, Impact on Therapeutic Response and Perspectives for Immunotherapy

(2021) Marine Leblond et al.   Cancers

Isorhapontigenin (ISO) inhibits EMT through FOXO3A/METTL14/VIMENTIN pathway in bladder cancer cells

(2021) Ning Zhang et al.   CANCER LETTERS

B7-H3 Suppresses Antitumor Immunity via the CCL2–CCR2–M2 Macrophage Axis and Contributes to Ovarian Cancer Progression

(2021) Taito Miyamoto et al.   Cancer Immunology Research

CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis

(2020) Hui Yang et al.   Molecular Cancer

MicroRNA-17-5p regulates EMT by targeting vimentin in colorectal cancer

(2020) Tae Won Kim et al.   BRITISH JOURNAL OF CANCER

Practicability of clinical application of bladder cancer molecular classification and additional value of epithelial-to-mesenchymal transition: prognostic value of vimentin expression

(2020) João Lobo et al.   Journal of Translational Medicine

Current status and future perspectives of immunotherapy in bladder cancer treatment

(2020) Zhangsong Wu et al.   Science China-Life Sciences

AKT-induced lncRNA VAL promotes EMT-independent metastasis through diminishing Trim16-dependent Vimentin degradation

(2020) Han Tian et al.   Nature Communications

MiR-483-3p regulates oxaliplatin resistance by targeting FAM171B in human colorectal cancer cells

(2019) Hui Liang et al.   Artificial Cells Nanomedicine and Biotechnology

Heterogeneous Nuclear Ribonucleoproteins Involved in the Functioning of Telomeres in Malignant Cells

(2019) Sergey Shishkin et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data

(2019) Francesca Finotello et al.   Genome Medicine

DIS3L2 promotes progression of hepatocellular carcinoma via hnRNP U-mediated alternative splicing

(2019) Huafeng Zhang et al.   CANCER RESEARCH

Regulation of CCL2 expression in human vascular endothelial cells by a neighboring divergently transcribed long noncoding RNA

(2019) Nadiya Khyzha et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment

(2019) Amy J. Petty et al.   JOURNAL OF CLINICAL INVESTIGATION

Long noncoding RNA LINC00675 enhances phosphorylation of vimentin on Ser83 to suppress gastric cancer progression

(2018) Shuo Zeng et al.   CANCER LETTERS

Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer

(2018) Hangcheng Fu et al.   CLINICAL CANCER RESEARCH

LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment

(2018) Changhao Chen et al.   Nature Communications

EMT Transition States during Tumor Progression and Metastasis

(2018) Ievgenia Pastushenko et al.   TRENDS IN CELL BIOLOGY

EMT: 2016

(2016) M. Angela Nieto et al.   CELL

Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma

(2015) Xiaoguang Li et al.   GUT

Diagnosis and Staging of Bladder Cancer

(2015) Maxine Sun et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment

(2015) Christopher G. Peña et al.   JOURNAL OF CLINICAL INVESTIGATION

Molecular Profiling Reveals a Tumor-Promoting Phenotype of Monocytes and Macrophages in Human Cancer Progression

(2014) Manesh Chittezhath et al.   IMMUNITY

Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis

(2014) Laura Bonapace et al.   NATURE